Provider review
Tuyo Health review
Advertises the brand drug at one price and charges twenty times that without insurance.
Its compounded side does the rare and useful thing: it states outright that pricing varies by dose, so the figures are labeled as floors rather than passed off as flat rates. Its brand cards advertise a copay while the cash-pay panel on the same page asks a different order of magnitude.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Tuyo Health
$155/mo sema · $279/mo tirz, varies by dose
FDA warning letter · Tuyo Health · September 2025 · addressed to Tuyo Health, Inc. dba Tuyo Health. Details in our review.
- Vs median
- $14/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
There are two tracks here and they are priced very differently in how honest they are with you. The compounded one is genuinely good: it says in the provider's own words that the price varies by dose, which is the single disclosure a low-dose reader needs and which most sellers replace with a flat-sounding figure that is nothing of the kind. Take that seriously — it means the quoted number is a floor the provider admits is a floor, and someone staying small has a reasonable expectation of paying near it. The brand track is where to be careful. Its cards lead with an insured copay, and the cash-pay panel a few inches down the same page asks a figure many times larger, plus a membership the compounded track does not charge. Both numbers are true. Which one applies to you is decided by a plan the page knows nothing about, and the card does not say so.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are staying at a low dose and want a provider that admits the price moves with it.
- You want the compounded track, which carries no membership fee and includes quarterly lab work.
- You want both a compounded and a brand-name route available from one place.
Look elsewhere if
- You are uninsured and read the brand cards first. The cash-pay figure is a different order of magnitude.
- You want a fixed number. Both compounded figures are floors, with no ceiling published.
- You want to know who compounds your medication before you order. No pharmacy is named.
What it actually costs
Price as published
Compounded semaglutide "As low as $155/mo" and compounded tirzepatide "As low as $279/mo", both explicitly annotated "Varies by dose, available upon evaluation" — a rare and welcome admission that the figure moves with the milligrams · the brand cards advertise Wegovy and Zepbound at "As low as $25/mo" while the cash-pay panel on the same page prices Wegovy at $499/month and Zepbound at $399/month plus a $99 membership: the $25 is an insured copay and the $499 is what you pay without it, a twentyfold gap decided by your plan rather than by anything on this page · the compounded track carries no membership fee; the brand track does · lab work every three months and a free clinical consultation stated as included
- Vs median
- $14/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Quotes off the lowest dose
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
36 of the 373 programs we track price a small dose this way. It says in its own words that pricing varies by dose, which on a general ranking reads as a warning and for someone deliberately staying small is the one structure that bills accordingly. The quoted figures are floors and the provider admits it, so a low-dose patient can at least expect to be near them rather than paying a full-dose rate for a quarter of the drug.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- States plainly that compounded pricing varies by dose, which is the disclosure a low-dose reader actually needs.
- No membership fee on the compounded track, with a free consultation and quarterly lab work stated as included.
- Carries both compounded and brand-name routes, and prices the cash-pay brand figures rather than hiding them.
Pharmacy, labs and oversight
Tuyo Health dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Tuyo Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Tuyo Health in September 2025. It is addressed to Tuyo Health, Inc. dba Tuyo Health — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Tuyo Health is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Tuyo Health runs two tracks and prices them on one screen, which is where the trouble starts. On the compounded side it states outright that pricing "varies by dose", so the quoted figures are labeled as starting points rather than passed off as flat rates. That is exactly the disclosure a low-dose reader needs, and it is the reason to take this row seriously. The brand side is the problem. Its cards advertise Wegovy and Zepbound at "as low as $25/mo", and the cash-pay panel a few inches away prices the same two drugs at $499 and $399 with a $99 membership on top. Both are true — the first with insurance, the second without — but a card that leads with $25 is describing an outcome that depends entirely on a plan the page knows nothing about.
The honest cons
Brand cards advertise "as low as $25/mo" while the cash-pay price on the same page is $499 and $399.
- The brand track adds a $99 membership fee the compounded track does not have.
- Both compounded figures are "as low as", and no ladder or ceiling is published for either.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Tuyo Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#153 of 373
Ordered with the companies that pay us first, and Tuyo Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Elara MD
$249/mo at 0.2 mg/wk semaglutide
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Compounded, 503A pharmacy
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Elara MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.